Effect of bromocriptine, a dopamine receptor agonist, on the experimentally induced gastric ulcers in albino rats

22Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The effect of bromocriptine, a dopamine receptor agonist, has been studied on the aspirin, phenylbutazone and reserpine induced gastric ulcers in rats. A single dose of bromocriptine 4 mg/kg s.c. produced a significant exacerbation of gastric ulcers induced by all the three ulcerogenic drugs, whereas in the same dose administered once daily for 5 consecutive days, it produced a marked protective effect in all the models. A review of the literature shows that different mechanisms may be involved in the opposite effects of acutely and chronically administered bromocriptine observed in this study. The study also points towards a role of dopamine in the pathogenesis of gastroduodenal ulceration. © 1984.

Cite

CITATION STYLE

APA

Parmar, N. S., Tariq, M., & Ageel, A. M. (1984). Effect of bromocriptine, a dopamine receptor agonist, on the experimentally induced gastric ulcers in albino rats. Life Sciences, 35(20), 2035–2039. https://doi.org/10.1016/0024-3205(84)90560-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free